| Page | ||
|---|---|---|
| General information |
||
| Report ofthe trustees | 3-5 | |
| Statement oftrustees' |
responsibilities | |
| Independent auditors' |
report | 7-10 |
| Statement offinancial | activities | |
| Balance sheet | 12 | |
| Cashflow statement | 13 | |
| Accounting policies |
14 - 15 | |
| Notes to the financial | statements | 16-21 |
| Unrestricted | Expendable | Total | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Income | endowment | this year | last year | |||||
| Note | Fund | Fund | 31.03.23 | 31.3.22 | ||||
| Income resources | ||||||||
| Voluntary Income |
||||||||
| Donations | 210,000 | 5,913,960 | 6,123,960 | 1,261,111 | ||||
| Gift aid refunds | 52,500 | 52,500 | 375,000 | |||||
| Investmentincome | 215,725 | 4,719 | 220,444 | 180,789 | ||||
| Total incoming recourses |
478 225 | 5,918,679 | 6,396,904 | 1,816,901 | ||||
| Resources expended | ||||||||
| Cost ofgenerating funds |
||||||||
| Investment management |
costs | 108,970 | 108,970 | 105,371 | ||||
| Charitable activities |
||||||||
| Grants and donations paid out |
120,000 | 120,000 | 1,643,009 | |||||
| Governance cost |
||||||||
| Trust accounting/tax claims fees |
9,263 | 9,263 | 9,128 | |||||
| Total resources expended | 129,263 | 108970 | 238233 | 1,757 509 | ||||
| Net incoming/(outgoing) before transfers |
resources | 348,963 | 5,809,709 | 6,158,671 | 59,391 | |||
| Gross transfers between |
funds | |||||||
| Net income/(outgoing) | resources before | |||||||
| other recognised gains |
and losses | 348,963' | . | 5,809,709 | 6,158,671 | 59,391 | ||
| Other recognised gains |
and losses | |||||||
| (Losses)/gains on investment assets |
(961,127) | (961,127) | 585,160 | |||||
| Net movements in funds |
348,963' | 4,848,582 | . | 5,197,544 | 644,551 | |||
| Fund balance brought forward at 31 March 2022 |
13,647,167 | 13,647,167 | 13,002,616 | |||||
| Fund balance carried forward at 31 March 2023 | 348,963 | 18495,748 | 18,844,711 | 13,647,167 | ||||
| 11 |
| Unrestricted | Expendable | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | Endowment | Total | Total | ||||||||
| fund | Fund | this year | last year | ||||||||
| 31.3.23 | 31.3.22 | ||||||||||
| Note | |||||||||||
| Fixed assets | |||||||||||
| Investment | at | market value | 6 | 353,614 | 19,478 250 | 19,831,864 | 15,115,329 | ||||
| Current assets | |||||||||||
| Oebtors | 1,010 | 1 010 | 78 350 | ||||||||
| Cash at bank | 6,039 | 6,039 | 36,952 | ||||||||
| Creditors: amounts | falling | due within one year | 8 | (11,700) | (572,502) | (584,202) | (628,464) | ||||
| Net current | assets | ~465& | ~572,502 | ~577,153 | ~513,162 | ||||||
| Total assets | less current | liabiiities | 348,963 | 18,905,748 | 19,254,711 | 14,602,167 | |||||
| Creditors: amounts | falling | due after one year | (410,000) | (410,000) | (955,000) | ||||||
| I1ietAssets | 348,963 | 18,495 748 | 18,844,711 | 13,647,167 | |||||||
| Funds | |||||||||||
| Expendable Unrestricted |
endowment income fund |
fund | 18,495,748 348 963 18,844,711 |
13,647,167 13,647,167 |
| Note | 31.3.23 | 31.3.22 | |
|---|---|---|---|
| Net income for the year | 6,158,671 | 59,391 | |
| Adjustments for |
|||
| Interest and dividends Decrease/(Increase) in debtors (Decrease)/Increase in creditors |
(220,444) 7?,340 (589,262) |
(180,789) (70,549) 958,124 |
|
| Cash flows from operating activities |
5,426,305 | 766,177 | |
| Cash flows from investing activities |
|||
| Interest and dividends Proceeds from sale of investments |
220,444 10,499,291 |
180,789 4 718654 |
|
| Purchase ofinvestments | (11,681,866) | (6,219,257) | |
| Net cash used by investing activities |
(962,131) | (1,319,814) | |
| Change in cash and cash equivalents Cash and cash equivalents brought forward Cash and cash equivalents carried forward |
12 | 4,464,173 681,848 5,146,021 |
(553,637) 1,235,484 681,848 |
| 31.3.23 | 31.03.22 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Investment income |
||||||||
| UKlncome Interest |
22,420 | 10,178 | |||||||
| Dividends | 33,780 | 21,710 | |||||||
| Accumulated | Dividends | - Expendable | endowment | 3,616 | 2,861 | ||||
| Property | 12,533 | 21,832 | |||||||
| Overseas Income Interest |
65,996 | 48,417 | |||||||
| Excess reportable Dividends |
income - Expendable | endowment | 1,103 80,995 |
2,298 73,493 |
|||||
| Property | |||||||||
| Investment income is unrestricted |
unless otherwise | stated | 220,444 | 180,789 | |||||
| 2 | Raising funds | ||||||||
| Portfolio management Less repaid commission |
108,970 108,970 |
107,733 2,362 105,371 |
|||||||
| 3 | Grants made | ||||||||
| The total grants made to institutions | during | the years was | as | follows: | |||||
| Medecins San Frontieres | 190,000 | ||||||||
| Supporting Dalit Children Marie Curie Cancer Care |
50,000 130,000 |
||||||||
| Mary's Meals St Mungo's Breast Cancer Now |
105,000 105,000 20,000 |
||||||||
| Prostate Cancer UK | 140,000 | ||||||||
| Youngminds Fair Trials International |
75,000 55,000 |
||||||||
| StGiles Trust | 85,000 | ||||||||
| Hardman Trust |
70,000 | ||||||||
| Anne Robson Trust | 55 000 | ||||||||
| Mind | 130,000 | ||||||||
| Herts Young Homeless Big issue Foundation Uhlock |
60,000 45,000 10,000 |
||||||||
| Cerabral Palsy Alliance Reseach SCI Foundation |
509 190,000 |
||||||||
| Arrhythmogenic Cardiomyopathy |
500 |
| 31.3.23 | 31.03.22 | ||
|---|---|---|---|
| Grants made. ...continued | E | ||
| Macmillian Cancer Support John Clemments Sports 8 Community Isobel Hospice Ltd Haileybury Youth Trust Samaritans Footsteps Foundation Tree Aid Envision The Haileybury Youth Trust British Heart Foundation Barts Charity Samaritans |
Trust | 1,000 35,000 1,000 8,000 5,000 50,000 20,000 |
5,000 1,000 50,000 20,000 20,000 25,000 1,000 5,000 |
| 120,000 | 1,643,009 |
| Further detail |
on commitments and on the actual cash disburs |
ed in the year is provided in note 14. |
||
|---|---|---|---|---|
| 4 | Governance | costs | ||
| Handelsbanken Audit fee Other |
Wealth Management | 6,000 2,700 563 |
6,000 2,700 428 |
|
| 9,263 | 9,128 |
| 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|
| F | F | |||||||
| 5 | Analysis of Funds | At 01-Apr-22 |
Income | Expenditure | Gains losses &transfers |
At 31-Mar-23 |
||
| restated | ||||||||
| F | F | F | F | |||||
| Unrestricted income funds Expendable endowment funds |
13,647,167 | 478,225 5,918,679 |
(129,263) (108,970) |
(961,127) | 348,963 18,495,748 |
|||
| 13647,167 | 6,396,904 | ~238,233 | ||||||
| At | Income | Expenditure | Gains losses | At | ||||
| 01-Apr-21 | &transfers | 31-Mar-22 | ||||||
| F | F. | F | ||||||
| Unrestricted income funds Expendable endowment funds |
0 13,002,616 |
175,630 1,641,271 |
(1,652,138) (105,371) |
1,476,508 (891,348) |
13,647,167 | |||
| 13,D02,617 | 1,816 9D1 | ~1,757,509 | ||||||
| 6 | Market value Carry (market) value at beginning ofyear Add Additions at cost Less disposals at carry value Add/(deduct) net gain/(loss) on revaluation Carry (market) value at end ofyear |
14,470,432 11,681,866 (10,499,291) 961,127 14,691,881 |
12,384,669 6,219,257 (4,718,654) 585,160 14,470,432 |
|||||
| Shares Portfolio Cash |
14,691,881 5,139,983 19,831,864 |
14,470,432 644,897 15,115,329 |
||||||
| Realised gains/(loss) Unrealised gains/(loss) |
on revaluation | (430,621) 530506 961 127 |
499,123 86,037 585,160 |
|||||
| The historic cost ofthese investments was |
f13,258,748 (2022: F12,321,275) | |||||||
| 7 | Oebtors | |||||||
| Prepayments and accrued income Gift aid refunds |
1,010 1,010 |
3,350 75,000 78,350 |
||||||
| 8 | Creditors: amount falling due |
within one year | ||||||
| Accruals and deferred Donation commitments |
income | 39,202 545,000 |
38,464 590,000 |
|||||
| 584 202 | 628,464 | |||||||
| 18 |
| 9 Creditors: amount | falling due after one year | ||||
|---|---|---|---|---|---|
| Donation commitments |
410,000 | 955,000 | |||
| 410,000 | 955,000 | ||||
| 10 Analysis of Net Assets between funds |
|||||
| Fund balances as at | 31 March 2023 are represented | by: | Expendable | ||
| Unrestricted | endowment | Total | |||
| Funds | Funds | Funds | |||
| E | |||||
| Fixed assets | 353,614 | 19,478,250 | 19,831,864 | ||
| Current assets | 7,049 | 7,049 | |||
| Current liabilities |
(11,700) | (572,502) | (584,202) | ||
| Non-current liabilities |
(410,000) | (410,000) | |||
| Total net assets | 348,983 | 18498748 | 18844711 | ||
| Analysis ofNet Assets between funds | |||||
| Fund balances as at | 31 March 2022 are represented | by: | Expendable | ||
| Unrestricted | endowment | Total | |||
| Funds | Funds | Funds | |||
| F | P | ||||
| Fixed assets | 15,115,329 | 15,115,329 | |||
| Current assets | 11,700 | 103,602 | 115,302 | ||
| Current liabilities |
(11,700) | (616,764) | (628,464) | ||
| ,Non-current liabilities |
(955,000) | (955,000) | |||
| Total net assets | 13647 167 | 13647 167 |
| 3Ts trust in the year en | 3Ts trust in the year en | ded 31 March 2022. | |||||
|---|---|---|---|---|---|---|---|
| 12 | Analysis of cash and | cash equivalents | 2023 | 2022 f |
|||
| Cash | in hand | 6,039 | 36,952 | ||||
| Cash | held within investments | 5,139,983 | 644,896 | ||||
| 5,146,022 | 681,848 | ||||||
| 13 | Analysis ofchanges | in net debt | |||||
| At 1 April | Cash flows | Other non- | At 31 March | ||||
| 2022 | cash | 2023 | |||||
| Changes | |||||||
| F | |||||||
| Cash | 36,952 | (30,913) | 6,039 | ||||
| Cash | equivalents | 644,896 | 4,495,087 | 5,139,983 | |||
| 681,848 | 4,464,173 | 5,146,022 | |||||
| Loans | falling due within | one year | |||||
| Finance lease obligations | |||||||
| 681 848 | 4464,173 | 5 146,022 |
| St Giles Trust | 75,000 | |
|---|---|---|
| St Mungo's | 105,000 | |
| Young Minds | 60,000 | |
| Prostate Cancer UK | 105,000 | |
| SCI Foundation | 150,000 | |
| Herls Young Homeless | 60,000 | |
| Hardman Trust |
60,000 | |
| Marie Curie | 105,000 | |
| Fair Trials International | 45,000 | |
| Mary's Meals | 105,000 | |
| Mbdecins san Frontihres |
150,000 | |
| Anne Robson Trust | 45,000 | |
| Big Issue Foundation | 45,000 | |
| Mind | 105,000 | |
| Dalit Children | 30 DOO | |
| 1,245,000 | ||
| Add pre-existing | commitments | 300,000 |
| 1,545,000 | ||
| Less paid in Year ended 31 March 2023 | 590,000 | |
| 955,0DD |
| Year | ended | 31 | March | 2024 | 545,000 |
|---|---|---|---|---|---|
| Year | ended | 31 | March | 2025 | 410000 |
| 955 000 |